Endocrinology, Vol 116, 113-117, Copyright © 1985 by Endocrine Society

ARTICLES

Characterization of adrenocorticotropin receptors that appear when 3T3- L1 cells differentiate into adipocytes

C Grunfeld, J Hagman, EA Sabin, DI Buckley, DS Jones and J Ramachandran

The binding of an 125I-labeled analog of ACTH, [125I]Tyr23,Phe2,Nle4- ACTH-(1-38), to differentiated 3T3-L1 fat cells was characterized. Time- dependent binding, which was inhibited by saturating concentrations of unlabeled ACTH (0.44 microM), could be demonstrated in the differentiated cells. Using 0.4 nM [125I]ACTH analog and increasing concentrations of ACTH, the half-maximal concentration for inhibition by ACTH was 4.3 nM. Scatchard analysis demonstrated a single class of ACTH binding. There were approximately 3500 binding sites/cell. The binding of [125I]ACTH analog was specific in that it could be displaced by ACTH, ACTH-(1-19), ACTH-(1-17), and N-acetyl-Ser1-ACTH, but not by high concentrations of insulin, beta-endorphin, or polylysine. There was an excellent correlation between the ability of ACTH and its analogs to inhibit [125I]ACTH analog binding and the ability of ACTH and its analogs to stimulate cAMP production. In contrast, no saturable binding could be demonstrated when undifferentiated 3T3-L1 fibroblasts, which are not responsive to ACTH, were studied. Thus, differentiation of 3T3-L1 cells into the adipocyte form is accompanied by the appearance of receptors for ACTH. These receptors allow the adipocytes to respond to ACTH.

This article has been cited by other articles:

				L. A. Noon, A. J. L. Clark, and P. J. King A Peroxisome Proliferator-response Element in the Murine mc2-r Promoter Regulates Its Transcriptional Activation during Differentiation of 3T3-L1 Adipocytes J. Biol. Chem., May 28, 2004; 279(22): 22803 - 22808. [Abstract] [Full Text] [PDF]

				F. M. Cammas, G. D. Pullinger, S. Barker, and A. J. L. Clark The Mouse Adrenocorticotropin Receptor Gene: Cloning and Characterization of Its Promoter and Evidence for a Role for the Orphan Nuclear Receptor Steroidogenic Factor 1 Mol. Endocrinol., June 1, 1997; 11(7): 867 - 876. [Abstract] [Full Text]